BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) had its price objective hoisted by equities researchers at BMO Capital Markets from $80.00 to $84.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has an "outperform" rating on the stock. BMO Capital Markets's target price would suggest a potential upside of 20.75% from the company's previous close.
A number of other brokerages also recently issued reports on BTSG. Wells Fargo & Company increased their price target on shares of BrightSpring Health Services from $78.00 to $82.00 and gave the company an "overweight" rating in a report on Monday, November 2nd. Weiss Ratings downgraded shares of BrightSpring Health Services from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday. UBS Group upped their target price on shares of BrightSpring Health Services from $85.00 to $92.00 and gave the stock a "buy" rating in a research report on Monday, November 2nd. KeyCorp reissued an "overweight" rating on shares of BrightSpring Health Services in a research note on Monday, August 3rd. Finally, TD Cowen boosted their target price on shares of BrightSpring Health Services from $81.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, November 2nd. Two research analysts have rated the stock with a Strong Buy rating and seventeen have assigned a Buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $78.69.
Read Our Latest Report on BrightSpring Health Services
BrightSpring Health Services Price Performance
BTSG stock traded down $0.27 on Wednesday, reaching $69.56. 132,577 shares of the company's stock were exchanged, compared to its average volume of 2,841,094. The stock has a fifty day moving average of $62.29 and a 200-day moving average of $56.37. BrightSpring Health Services has a twelve month low of $31.42 and a twelve month high of $73.75. The firm has a market cap of $13.84 billion, a PE ratio of 37.58, a P/E/G ratio of 0.78 and a beta of 1.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.99.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its quarterly earnings data on Friday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.07. The firm had revenue of $4.21 billion during the quarter, compared to analysts' expectations of $3.88 billion. BrightSpring Health Services had a return on equity of 18.56% and a net margin of 2.69%. The company's revenue was up 26.4% compared to the same quarter last year. As a group, equities analysts predict that BrightSpring Health Services will post 1.70 EPS for the current fiscal year.
Institutional Trading of BrightSpring Health Services
Large investors have recently bought and sold shares of the company. New York State Common Retirement Fund grew its holdings in BrightSpring Health Services by 1.8% in the 3rd quarter. New York State Common Retirement Fund now owns 59,155 shares of the company's stock worth $3,357,000 after buying an additional 1,054 shares in the last quarter. Allworth Financial LP lifted its holdings in BrightSpring Health Services by 56.3% in the third quarter. Allworth Financial LP now owns 633 shares of the company's stock worth $36,000 after purchasing an additional 228 shares during the period. Quantitative Investment Management LLC bought a new position in BrightSpring Health Services in the 3rd quarter valued at about $687,000. Readystate Asset Management LP bought a new position in BrightSpring Health Services in the 3rd quarter valued at about $286,000. Finally, Goldman Sachs Group Inc. increased its stake in BrightSpring Health Services by 1.1% during the 3rd quarter. Goldman Sachs Group Inc. now owns 1,636,838 shares of the company's stock valued at $92,891,000 after buying an additional 18,403 shares during the period.
BrightSpring Health Services Company Profile
(
Get Free Report)
BrightSpring Health Services is a provider of home- and community-based health services in the United States. The company supports people with complex health needs, including individuals with intellectual and developmental disabilities, behavioral health conditions, and chronic or age-related illnesses. Its services include home health and hospice care, behavioral health and rehabilitation, residential and community-based support, and pharmacy services. BrightSpring's pharmacy operations provide prescription dispensing and related services to people receiving care in homes, community settings, and long-term care facilities.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.